Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.
Stinchcomb AL, Valiveti S, Hammell DC, Ramsey DR. Stinchcomb AL, et al. Among authors: hammell dc. J Pharm Pharmacol. 2004 Mar;56(3):291-7. doi: 10.1211/0022357022791. J Pharm Pharmacol. 2004. PMID: 15025853
Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin.
Stinchcomb AL, Swaan PW, Ekabo O, Harris KK, Browe J, Hammell DC, Cooperman TA, Pearsall M. Stinchcomb AL, et al. Among authors: hammell dc. J Pharm Sci. 2002 Dec;91(12):2571-8. doi: 10.1002/jps.10239. J Pharm Sci. 2002. PMID: 12434400
In vitro/in vivo correlation studies for transdermal delta 8-THC development.
Valiveti S, Hammell DC, Earles DC, Stinchcomb AL. Valiveti S, et al. Among authors: hammell dc. J Pharm Sci. 2004 May;93(5):1154-64. doi: 10.1002/jps.20036. J Pharm Sci. 2004. PMID: 15067692
Transdermal permeation of WIN 55,212-2 and CP 55,940 in human skin in vitro.
Valiveti S, Kiptoo PK, Hammell DC, Stinchcomb AL. Valiveti S, et al. Among authors: hammell dc. Int J Pharm. 2004 Jun 18;278(1):173-80. doi: 10.1016/j.ijpharm.2004.03.009. Int J Pharm. 2004. PMID: 15158959
A duplex "Gemini" prodrug of naltrexone for transdermal delivery.
Hammell DC, Hamad M, Vaddi HK, Crooks PA, Stinchcomb AL. Hammell DC, et al. J Control Release. 2004 Jun 18;97(2):283-90. doi: 10.1016/j.jconrel.2004.03.020. J Control Release. 2004. PMID: 15196755
Transdermal delivery of the synthetic cannabinoid WIN 55,212-2: in vitro/in vivo correlation.
Valiveti S, Hammell DC, Earles DC, Stinchcomb AL. Valiveti S, et al. Among authors: hammell dc. Pharm Res. 2004 Jul;21(7):1137-45. doi: 10.1023/b:pham.0000032999.31948.2e. Pharm Res. 2004. PMID: 15290852
In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs.
Valiveti S, Hammell DC, Paudel KS, Hamad MO, Crooks PA, Stinchcomb AL. Valiveti S, et al. Among authors: hammell dc. J Control Release. 2005 Feb 2;102(2):509-20. doi: 10.1016/j.jconrel.2004.10.005. J Control Release. 2005. PMID: 15653167
Bioconversion of naltrexone and its 3-O-alkyl-ester prodrugs in a human skin equivalent.
Hammell DC, Stolarczyk EI, Klausner M, Hamad MO, Crooks PA, Stinchcomb AL. Hammell DC, et al. J Pharm Sci. 2005 Apr;94(4):828-36. doi: 10.1002/jps.20238. J Pharm Sci. 2005. PMID: 15736197
LC-MS method for the estimation of delta8-THC and 11-nor-delta8-THC-9-COOH in plasma.
Valiveti S, Hammell DC, Earles DC, Stinchcomb AL. Valiveti S, et al. Among authors: hammell dc. J Pharm Biomed Anal. 2005 Jun 1;38(1):112-8. doi: 10.1016/j.jpba.2004.11.055. Epub 2005 Jan 5. J Pharm Biomed Anal. 2005. PMID: 15907628
In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs.
Valiveti S, Paudel KS, Hammell DC, Hamad MO, Chen J, Crooks PA, Stinchcomb AL. Valiveti S, et al. Among authors: hammell dc. Pharm Res. 2005 Jun;22(6):981-9. doi: 10.1007/s11095-005-4593-0. Epub 2005 Jun 8. Pharm Res. 2005. PMID: 15948042
37 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback